Clinical Trials Sponsored by Clinident Institute

Total 74453 results

National Cancer Institute (NCI)

Completed

Retrospective Review of FDG PET MRI Management of Patients With Muscle Invasive Bladder Cancer

Bladder Cancer

United States
National Cancer Institute (NCI)

Terminated

M7824 (MSB0011359C) in Combination With Gemcitabine in Adults With Previously Treated Advanced Adenocarcinoma of the Pancreas

Pancreatic Neoplasms | Pancreatic Cancer | Pancreatic Adenocarcinoma | Pancreas Cancer | Cancer of Pancreas

United States
National Cancer Institute (NCI)

Completed

Treatment of Castration Resistant Prostate Cancer Using Multi-Targeted Recombinant Ad5 PSA/MUC1/Brachyury Based Immunotherapy Vaccines

Prostatic Neoplasms | Prostatic Cancer

United States
National Cancer Institute (NCI)

Completed

Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer

Pancreatic Neoplasms | Pancreatic Cancer | Pancreas Cancer | Cancer of Pancreas | Cancer of the Pancreas

United States
National Cancer Institute (NCI)

Completed

T Cell Receptor Immunotherapy Targeting NY-ESO-1 for Patients With NY-ESO-1 Expressing Cancer

Melanoma | Breast Cancer | Non-Small Cell Lung Cancer | Meningioma | Hepatocellular Cancer

United States
National Cancer Institute (NCI)

Completed

Risk Factors for Non-HIV-Related Kaposi s Sarcoma

Kaposi's Sarcoma

Italy
National Cancer Institute (NCI)

Terminated

Natural History Study of Monoclonal Gammopathy of Undetermined Significance (MGUS) and Smoldering Myeloma (SMM)

Monoclonal Gammopathy of Undetermined Significance | Smoldering Myeloma

United States
National Cancer Institute (NCI)

Completed

The Effects of Genetic Differences Among AIDS Patients on Cytomegalovirus Retinitis

AIDS

United States
National Cancer Institute (NCI)

Completed

Effect of Genetic Differences on Levels of Water Disinfection Byproducts in Blood After Showering

Normal Physiology

United States
National Cancer Institute (NCI)

Completed

Study to Estimate Radiation Doses and Cancer Risks From Radioactive Fallout From the Trinity Nuclear Test

Cancers

United States
National Cancer Institute (NCI)

Withdrawn

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab

Metastatic HPV-16 Positive Squamous Cell Anal Cancer

United States
National Cancer Institute (NCI)

Terminated

Vandetanib in Combination With Metformin in People With HLRCC or SDH-Associated Kidney Cancer or Sporadic Papillary Renal Cell Carcinoma

Renal Cell Carcinoma | Renal Cell Cancer | Hereditary Leiomyomatosis

United States
National Cancer Institute (NCI)

Completed

Case-Control Study of Renal Cell Cancer Among Caucasions and African Americans in the United States

Kidney Cancer | Renal Cell Carcinoma

United States
National Cancer Institute (NCI)

Completed

Vandetanib to Treat Children and Adolescents With Medullary Thyroid Cancer

Multiple Endocrine Neoplasia Type 2A | Multiple Endocrine Neoplasia Type 2B | Medullary Thyroid Carcinoma

United States
National Cancer Institute (NCI)

Completed

A Pilot Study of Metformin in Patients With a Diagnosis of Li-Fraumeni Syndrome

Li-Fraumeni Syndrome

United States
National Cancer Institute (NCI)

Completed

Family Study of Head and Neck Cancers in Taiwan

Nasopharyngeal Neoplasms | Herpesvirus 4, Human

China
Yale University
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

Optimizing Tobacco Dependence Treatment in the Emergency Department

Tobacco Use Disorder

United States
National Cancer Institute (NCI)

Completed

Smoky Coal Exposure, Genetic Susceptibility, and Lung Cancer in Non-Smoking Women in China

Lung Neoplasms

China
National Cancer Institute (NCI)

Completed

Human Papillomavirus Epidemiology in Nigeria

Cervical Intraepithelial Neoplasia | Uterine Cervical Neoplasms | Human Papillomavirus 16 | Human Papillomavirus 18

Nigeria
National Cancer Institute (NCI)

Completed

Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal Cancer

Fallopian Tube Cancer | Primary Peritoneal Cancer | Ovarian Neoplasm

United States
National Cancer Institute (NCI)

Completed

Benign Reproductive Tissue Analysis for Endometrial Cancer Markers

Hysterectomy | Oophorectomy for Benign Reasons

United States
National Cancer Institute (NCI)

Completed

Studying Blood Toxicity in Workers Exposed to Formaldehyde

Blood | Chemical Industry

China
National Cancer Institute (NCI)

Completed

Continuation of Follow-up of DES-Exposed Cohorts

Breast Cancer | Ovarian Cancer | Prostate Cancer | Endometrial Cancer | Autoimmune Disease

United States
National Cancer Institute (NCI)

Completed

Anal Cancer Screening Study

Anal Cancer

United States
National Cancer Institute (NCI)

Completed

Tocilizumab for KSHV-Associated Multicentric Castleman Disease

Castleman Disease | Multicentric Castleman Disease | Giant Lymph Node Hyperplasia

United States
National Cancer Institute (NCI)

Completed

Interdisciplinary Case-Control Study of Bladder Cancer in Spain

Bladder Cancer

Spain
National Cancer Institute (NCI)

Completed

Eligibility Screening for a NCI Pediatric Oncology Branch Research Study

Osteosarcoma | Acute Lymphoblastic Leukemia | Ewing Sarcoma | Neurofibromatosis Type 1 | Neuroblastoma

United States
National Cancer Institute (NCI)

Completed

Molecular Profiling of Stage II and III Breast Cancer in Latin American Women Receiving Standard-of-Care Treatment

Breast Cancer

Mexico, Argentina, Brazil, Chile, Uruguay
National Cancer Institute (NCI)

Withdrawn

Biospecimen Procurement for Immunological Landscape Studies Following Hematopoietic Cell Transplantation

Hematopoietic Stem Cell Transplantation | Hematologic Malignancies | Cell Transplantation

United States
Navidea Biopharmaceuticals
National Cancer Institute (NCI); National Institutes of Health (NIH)

Terminated

An Evaluation of Tilmanocept by IV Injection Using SPECT/CT vs PET Imaging in Subjects With Liver Metastases.

Liver Metastases | Colorectal Carcinoma

United States
National Cancer Institute (NCI)

Completed

Evaluation, Treatment, and Natural History of Children and Young Adults With Cancer or Rare Diseases

Lymphoma | Leukemia | Brain Tumors | Rhabdomyosarcoma | Ewing's Sarcoma

United States
National Cancer Institute (NCI)

Completed

Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced Cancer

Neoplasms | Breast Cancer | Lung Cancer | Prostate Cancer | Colon Cancer

United States
National Cancer Institute (NCI)

Completed

Preliminary Study of Endometrial Hyperplasia Groundwork for a Study to Define Precursors of Endometrial Cancer

Endometrial Hyperplasia | Endometrial Cancer | Vaginal Bleeding | Postmenopausal Bleeding

United States
Navidea Biopharmaceuticals
National Cancer Institute (NCI); National Institutes of Health (NIH)

Completed

An Evaluation of Tc 99m Tilmanocept by Intravenous (IV) and Subcutaneous (SC) Injection in Kaposi Sarcoma (KS)

HIV Infections | Kaposi Sarcoma

United States
National Cancer Institute (NCI)

Completed

Study of Health Effects of Cosmetic Breast Augmentation

Breast Cancer | Lung Cancer | Suicide | Brain Cancer

United States
National Eye Institute (NEI)

Completed

Pilot Study of the Evaluation of Subconjunctival Sirolimus in the Treatment of Bilateral GA Associated With AMD (SIRGA)

Age-Related Macular Degeneration

United States
National Cancer Institute (NCI)

Completed

Genetic Aspects of Chordoma: A Collaboration With SEER Registries to Identify Chordoma Families

Chordoma

United States
National Cancer Institute (NCI)

Completed

Assessment of Blood Vessel Density in Kaposi's Sarcoma Lesions

Kaposi's Sarcoma

United States
National Cancer Institute (NCI)

Completed

Family Study of Melanoma in Italy

Melanoma | Dysplastic Nevi | Melanocytic Nevi

Spain, Italy
National Cancer Institute (NCI)

Completed

Molecular Epidemiology of Cutaneous Malignant Melanoma

Melanoma

United States
National Eye Institute (NEI)

Completed

Sirolimus Injections for Autoimmune Scleritis (ISAS)

Scleritis

United States
National Cancer Institute (NCI)

Completed

Follow-Up Study of Kidney Cancer Patients

Renal Cancer

Czechia, Poland
National Cancer Institute (NCI)

Completed

Evaluation of Skin, Colonic, and Oral Microbiome and Effect of Time and Antibiotic Treatment on Organism Diversity at Each Site

BMI | General Demographics Characteristics

Costa Rica
National Cancer Institute (NCI)

Terminated

Defining the Clinical Utility of EBV Antibody Screening to Identify Individuals Susceptible to Nasopharyngeal Carcinoma (NPC) Within High-Risk, Multiplex NPC Families

Nasopharyngeal Neoplasms

China
National Cancer Institute (NCI)

Completed

Early Detection of Barrett's Esophagus

Barrett's Esophagus

United States
National Cancer Institute (NCI)

Completed

Intraprostatic Androgenicity in Relation to Circulating Levels of Hormones and Polymorphisms of Hormone-Related Genes: A Methodologic Study

Prostate

United States, China
National Cancer Institute (NCI)

Terminated

NCI UNC Project ESCC

Esophageal Squamous Cell Carcinoma

Malawi
National Cancer Institute (NCI)

Completed

DNA Repair, p53 and Apoptosis Phenotypes in Lung Cancer

Lung Neoplasms

United States
National Cancer Institute (NCI)

Completed

Pilot Study of Educational Interventions in Pediatric Hematopoietic Stem Cell Donors to Increase Knowledge of Donation and Transplantation Procedures

Normal Donors

United States
National Cancer Institute (NCI)

Completed

Study of Plexiform Neurofibromas in Neurofibromatosis Type 1

Plexiform Neurofibromas | NF1

United States

Clinical Trials Sponsored by Clinident Institute

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations